169 related articles for article (PubMed ID: 17241287)
41. Sequential bilateral striatal lesions have additive effects on single skilled limb use in rats.
Faraji J; Metz GA
Behav Brain Res; 2007 Feb; 177(2):195-204. PubMed ID: 17182115
[TBL] [Abstract][Full Text] [Related]
42. Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion.
Nielsen KM; Soghomonian JJ
Synapse; 2003 Sep; 49(4):246-60. PubMed ID: 12827644
[TBL] [Abstract][Full Text] [Related]
43. Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats.
Bové J; Marin C; Bonastre M; Tolosa E
Synapse; 2002 Dec; 46(4):251-7. PubMed ID: 12373740
[TBL] [Abstract][Full Text] [Related]
44. Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.
Henderson JM; Stanic D; Tomas D; Patch J; Horne MK; Bourke D; Finkelstein DI
Behav Brain Res; 2005 May; 160(2):267-76. PubMed ID: 15863223
[TBL] [Abstract][Full Text] [Related]
45. Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat.
Duty S; Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1998 Apr; 150(2):223-34. PubMed ID: 9527891
[TBL] [Abstract][Full Text] [Related]
46. Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats.
Périer C; Vila M; Féger J; Agid Y; Hirsch EC
Exp Neurol; 2000 Mar; 162(1):215-24. PubMed ID: 10716902
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
[TBL] [Abstract][Full Text] [Related]
48. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
[TBL] [Abstract][Full Text] [Related]
49. Cocaine reverses the changes in GABAA subunits and in glutamic acid decarboxylase isoenzymes mRNA expression induced by neonatal 6-hydroxydopamine.
de Azeredo LA; Marquardt AR; Frazzon AP; Barros HM
Behav Pharmacol; 2010 Jul; 21(4):343-52. PubMed ID: 20581658
[TBL] [Abstract][Full Text] [Related]
50. Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
Lee J; Gomez-Ramirez J; Johnston TH; Visanji N; Brotchie JM
Synapse; 2008 Apr; 62(4):310-3. PubMed ID: 18241048
[TBL] [Abstract][Full Text] [Related]
51. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
52. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
Giorgi M; D'Angelo V; Esposito Z; Nuccetelli V; Sorge R; Martorana A; Stefani A; Bernardi G; Sancesario G
Eur J Neurosci; 2008 Sep; 28(5):941-50. PubMed ID: 18717735
[TBL] [Abstract][Full Text] [Related]
53. Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract.
Pum ME; Schäble S; Harooni HE; Topic B; De Souza Silva MA; Li JS; Huston JP; Mattern C
Neuroscience; 2009 Aug; 162(1):174-83. PubMed ID: 19401223
[TBL] [Abstract][Full Text] [Related]
54. NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.
Wessell RH; Ahmed SM; Menniti FS; Dunbar GL; Chase TN; Oh JD
Neuropharmacology; 2004 Aug; 47(2):184-94. PubMed ID: 15223297
[TBL] [Abstract][Full Text] [Related]
55. Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa.
Guan Q; Zhan Q; He Y; Tan L
Neurosci Lett; 2007 Oct; 426(1):64-8. PubMed ID: 17884291
[TBL] [Abstract][Full Text] [Related]
56. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
57. Behavioral and subthalamic effects of combining a fetal ventral mesencephalic transplant in striatum with an electrolytic lesion of the entopeduncular nucleus in the rat with a unilateral 6-OHDA lesion of substantia nigra.
Olds ME; Jacques DB; Kopyov O
Synapse; 2003 May; 48(2):90-9. PubMed ID: 12619043
[TBL] [Abstract][Full Text] [Related]
58. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
Sedaghat K; Finkelstein DI; Gundlach AL
Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
[TBL] [Abstract][Full Text] [Related]
59. Relevance between striatal expression of Fos, proenkephalin mRNA, prodynorphin mRNA and rotation induced by l-stepholidine in 6-hydroxydopamine-lesioned rats.
Ding YM; Tang FM; Yu LP; Fu Y; Zhang GY; Jin GZ
Acta Pharmacol Sin; 2000 Oct; 21(10):885-92. PubMed ID: 11501038
[TBL] [Abstract][Full Text] [Related]
60. 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.
Rangel-Barajas C; Silva I; García-Ramírez M; Sánchez-Lemus E; Floran L; Aceves J; Erlij D; Florán B
Neuropharmacology; 2008 Oct; 55(5):704-11. PubMed ID: 18588904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
